$ALXN Company News Nasdaq pummeled in worst day since

New Post Public Reply Private Reply Replies (0) Message Board

Apr 11, 2014 at 11:35 AM

$ALXN Company News

Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 4:53 p.m. April 10, 2014 - blogs.marketwatch.com
TripAdvisor, Tesla sink as momentum plays lose favor 4:36 p.m. April 10, 2014 - Saumya Vaishampayan
Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - blogs.marketwatch.com
Tesla, Facebook, Netflix are Monday’s stocks to watch 5:35 a.m. April 7, 2014 - Sue Chang
Facebook, Tesla slide into bear market territory 4:52 p.m. April 4, 2014 - Saumya Vaishampayan
Investors continue to pour out of biotech holdings 2:43 p.m. April 4, 2014 - Russ Britt
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 4:40 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 4:23 p.m. March 24, 2014 - Ben Eisen
First Solar, H-P, Symantec are stocks to watch 4:15 p.m. March 21, 2014 - Sue Chang
First Solar extends winning streak; Symantec plunges 3:06 p.m. March 21, 2014 - Ben Eisen
From every angle, technicals point to richer stocks 2:25 p.m. March 11, 2014 - The Trading Deck
U.S. stocks fall amid China worries 4:19 p.m. March 10, 2014 - Anora Mahmudova
Alexion rallies on upbeat outlook; Cliffs down on China 4:17 p.m. March 10, 2014 - Saumya Vaishampayan
Alexion bucks tide, gains on deal with France for blood disorder treatment 11:58 a.m. March 10, 2014 - blogs.marketwatch.com
Winning approval for new drugs may get harder, analyst warns 3:56 p.m. Feb. 28, 2014 - blogs.marketwatch.com
Yelp up on Yahoo deal; Apple gains as Icahn backs off 3:30 p.m. Feb. 10, 2014 - Saumya Vaishampayan
Corrective bounce, or viable market rally attempt? 11:34 a.m. Feb. 10, 2014 - Michael Ashbaugh
Utility stocks gain as Treasury yields lag 4:06 p.m. Feb. 4, 2014 - Wallace Witkowski
S&P 500 scores its best gain this year: stock market live blog recap 4:13 p.m. Jan. 30, 2014 - blogs.marketwatch.com

Rite Aid (RAD) Jumps: Stock Up 8.4% - Tale of the Tape 9:39 a.m. Today - Zacks.com
Celladon (CLDN) Jumps: Stock Up 11.5% - Tale of the Tape 8:51 a.m. Today - Zacks.com
Biotech Stocks' Rout Perplexes Analysts 6:23 p.m. April 10, 2014 - The Wall Street Journal Interactive Edition
Market Hustle: Nasdaq Sees Biggest Fall Since Mid-2012 4:17 p.m. April 10, 2014 - TheStreet.com
Oh Biotech, You Are a Cruel Bitch 1:09 p.m. April 10, 2014 - TheStreet.com
3 Top-Ranked Biotech Stocks on the Rebound - Analyst Blog 9:22 a.m. April 10, 2014 - Zacks.com
Nobody Expects a Spanish Disquistion 11:14 a.m. April 9, 2014 - Barrons.com
Alexion, Biogen Among Leading Big-Cap Biotechs 7:02 a.m. April 9, 2014 - Investors Business Daily
EPO Upholds Alnylam's McSwiggen Patent - Analyst Blog 7:00 p.m. April 8, 2014 - Zacks.com
Encouraging Pre-Clinical Data from Celldex - Analyst Blog 5:40 p.m. April 8, 2014 - Zacks.com
Intercept Pharma Prices 1M Share Offering, Shares Down - Analyst Blog 5:00 p.m. April 8, 2014 - Zacks.com
Pipeline Update from Idenix - Analyst Blog 4:55 p.m. April 8, 2014 - Zacks.com
A Sharp Pullback In Celldex Could Be A Window Of Opportunity 3:41 p.m. April 8, 2014 - Seeking Alpha
Halozyme Falls on Phase II Study Halt - Analyst Blog 12:10 p.m. April 8, 2014 - Zacks.com
Bristol-Myers Seeks FDA Approval for HCV Candidates - Analyst Blog 11:40 a.m. April 8, 2014 - Zacks.com
FDA Target Date for Gilead's HCV Candidate - Analyst Blog 11:30 a.m. April 8, 2014 - Zacks.com
RadNet Touches New 52-Week High - Analyst Blog 10:26 a.m. April 8, 2014 - Zacks.com
Idenix Pharmaceuticals (IDIX) Jumps: Stock Up 12.4% - Tale of the Tape 8:51 a.m. April 8, 2014 - Zacks.com
Puma Biotechnology (PBYI) in Focus: Stock Tumbles 18.3% - Tale of the Tape 8:45 a.m. April 8, 2014 - Zacks.com
Questcor Pharmaceuticals (QCOR) Shows Strength: Stock Surges 18.7% in Session - Tale of the Tape 8:44 a.m. April 8, 2014 - Zacks.com

Alexion Pharmaceuticals to Report First Quarter 2014 Results on Thursday, April 24, 2014 10:01 a.m. April 10, 2014 - BusinessWire - BZX
BioMed Realty Invests In Life Science Research Facilities Leased To Yale University, Yale-New Haven Hospital And Alexion Pharmaceuticals 7:00 a.m. April 7, 2014 - PR Newswire - PRF
Study Results, Stock Price Movements, Product Launches, and Updates on Court Case Trials - Analyst Notes on Medtronic, Alexion, DaVita, Thermo Fisher Scientific, and Medicines 8:00 a.m. April 4, 2014 - PR Newswire - PRF
Drug Approvals, Stock Price Movements, and New Tools for Standardization - Analyst Notes on Biogen Idec, Alexion, Actavis, Thermo Fisher Scientific, and Medtronic 8:00 a.m. March 26, 2014 - PR Newswire - PRF
Pre-market Biotech Picks -- Research on Merrimack Pharma, Alexion Pharma, Incyte, and Aastrom Biosciences 11:25 a.m. March 25, 2014 - PR Newswire - PRF
Conference Schedules, Upcoming Marathon Applications, Revised Guidance, and Acquisitions - Analyst Notes on Celgene, Medtronic, Alexion, Quest Diagnostics, and Illumina 8:00 a.m. March 14, 2014 - PR Newswire - PRF
Alexion Revises Upward 2014 Financial Guidance for Revenues and non-GAAP EPS 6:31 a.m. March 10, 2014 - BusinessWire - BZX
Collaborations, Conferences, and Recognitions - Analyst Notes on Illumina, Alexion, Medtronic, Sirona, and NPS Pharmaceuticals 2:08 p.m. March 5, 2014 - PR Newswire - PRF
Alexion to Present at the Barclays Global Healthcare Conference 11:00 a.m. March 5, 2014 - BusinessWire - BZX
Critical Alerts For Baidu.com, Gilead Sciences, Deere, Alexion Pharmaceuticals, and Ford Released By InvestorsObserver 10:31 a.m. March 5, 2014 - PR Newswire - PRF
NICE Confirms AGNSS Positive Assessment that Eculizumab (Soliris®) is a Very Effective Treatment for aHUS Patients and Produces Substantial Quality-Adjusted Life Year Gains of a Magnitude Rarely Seen for a New Drug 8:02 p.m. March 3, 2014 - BusinessWire - BZX
Alexion Joins Patient Organizations Worldwide in Recognizing Rare Disease Day 2014 3:01 a.m. Feb. 28, 2014 - BusinessWire - BZX
Alexion to Present at the Cowen and Company 34th Annual Health Care Conference 11:01 a.m. Feb. 25, 2014 - BusinessWire - BZX
European Commission Grants Orphan Drug Designation to Soliris® (Eculizumab) for Prevention of Delayed Graft Function (DGF) after Solid Organ Transplantation 7:30 a.m. Feb. 24, 2014 - BusinessWire - BZX
Critical Alerts For Twitter, Alexion Pharmaceuticals, Pfizer, Ctrip, and AngloGold Ashanti Released By InvestorsObserver 10:31 a.m. Jan. 31, 2014 - PR Newswire - PRF
Alexion Reports Fourth Quarter and Full Year 2013 Results and Provides Financial Guidance for 2014 7:31 a.m. Jan. 30, 2014 - BusinessWire - BZX
FDA Grants Orphan Drug Designation to Soliris® (eculizumab) for Prevention of Delayed Graft Function (DGF) in Renal Transplant Patients 7:30 a.m. Jan. 21, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2013 Results on Thursday, January 30, 2014 11:00 a.m. Jan. 16, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals and Moderna Therapeutics Announce Exclusive Strategic Agreement to Develop Messenger RNA Therapeutics™ for Rare Diseases 7:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Upcoming Presentations and Stock Price Movements - Research Report on Bard, Regeneron, Alexion, Seattle Genetics, and Isis Pharmaceuticals 9:00 a.m. Jan. 9, 2014 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DKS Lawsuit Deadline: Investors Must Act by Nov 3, 2026

Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...

GAC Dominates with 8 Awards in Cutting-Edge Tech

GAC's Moment in the Spotlight Wow, did ya hear about GAC grabbing eight shiny awards at the China-SAE Science and Technology gig? That ain't small potatoes, especially when you're bagging four first prizes. These fellas in Suzhou on October 28 sure showed they're not just playing in the sandbox but are ready to build the darn thing. There's power, and then there's GAC's...

Naviu's AI Travel Guide: Revolutionizing Japan Tours

A New Era of Touring Japan: Meet Naviu Alright, travelers, strap in—Naviu is about to flip your trip to Japan upside down. Launching November 1st, 2026, this AI-powered augmented reality travel companion is trying to make exploring Japan easier than ever. Behind this innovative gem is TANGLE Inc., working with technology so cutting-edge, it's practically slicing through...

Fluence Energy Faces Class Action: Investors Beware

Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...

China-Malaysia Youth Dialogue: Tackling Ocean Challenges

Building Bridges Across Waters These aren't the afternoons of trading stocks, folks—this one dives into the depths of the ocean and the tumultuous waters between China and Malaysia. October 30 saw the China-Malaysia Youth Ocean Dialogue take place at the China Media Group Sanya Studio, bringing together some sharp minds from both nations, tackling something that goes...

Voting for Future Urban Icons Begins Globally

New Era for Urban Innovations Takes Center Stage Here's a twist folks didn't see coming: Future cities aren't just the stuff of sci-fi flicks anymore. We've got a global stage now—real, live, and buzzing with excitement from New Clark City in the Philippines. On October 31, 2026, they pulled back the curtain on 7wondersfc.com, flipping the switch on a worldwide voting...

Yangtze River Culture Festival Spotlights Integration, Tradition

A Celebration of Culture and Integration Here's an event that flips the script on the typical festival circuit: the 2026 Yangtze River Culture Festival. It's as much about heritage as it is about economics, dovetailing culture with tourism in a way that makes wallets a little fatter and souls a little richer. Kicking off in Yonglian Village, Zhangjiagang, this festival...

Karma Automotive Debuts High-Stakes Eximius Program

Breaking Ground with Bespoke Engineering Fancy seeing a car more unique than a snowflake, eh? Well, Karma Automotive is upending the luxury vehicle market with the launch of the Eximius program. Catering to the whims of the elite who aren’t just satisfied with a plethora of options, this is a game for those who crave a motorized extension of their ego and address book....

Bass Angler Matt Robertson Reels in Record $1.25M Prize

A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...

XPeng Hits New Monthly Delivery Record in October

XPeng Smashes Delivery Records Yet Again Ah, the green light’s on for XPeng, and it's a bright one! This October, we learned that XPeng hit the throttle hard with a new record of 50,237 vehicles delivered. Now, that's a sizable rally—a 22% climb month-over-month and shooting 20% higher than last October. For a company like XPeng, which resembles a bulldog with its...